Johnson Kevin C 4
4 · NEOGENOMICS INC · Filed Nov 4, 2019
Insider Transaction Report
Form 4
Johnson Kevin C
Director
Transactions
- Exercise/Conversion
Common Stock
2019-10-31$7.27/sh+6,666$48,462→ 49,951 total - Exercise/Conversion
Common Stock
2019-10-31$9.11/sh+8,333$75,914→ 43,285 total - Exercise/Conversion
Stock Option (Right to Buy)
2019-10-31−8,333→ 0 totalExercise: $9.11From: 2017-07-28Exp: 2021-07-28→ Common Stock (8,333 underlying) - Exercise/Conversion
Common Stock
2019-10-31$4.78/sh+6,667$31,868→ 34,952 total - Exercise/Conversion
Stock Option (Right to Buy)
2019-10-31−6,667→ 0 totalExercise: $4.78From: 2016-05-06Exp: 2020-05-06→ Common Stock (6,667 underlying) - Exercise/Conversion
Common Stock
2019-10-31$11.60/sh+3,017$34,997→ 52,968 total - Exercise/Conversion
Stock Option (Right to Buy)
2019-10-31−6,666→ 3,334 totalExercise: $7.27From: 2018-05-25Exp: 2022-05-25→ Common Stock (6,666 underlying) - Exercise/Conversion
Stock Option (Right to Buy)
2019-10-31−3,017→ 0 totalExercise: $11.60From: 2019-06-01Exp: 2023-06-01→ Common Stock (3,017 underlying)
Holdings
- 4,269
Stock Option (Right to Buy)
Exercise: $22.52From: 2020-06-06Exp: 2026-06-06→ Common Stock (4,269 underlying)
Footnotes (3)
- [F1]On May 6, 2015 Mr. Johnson was granted 10,000 stock options. The options vest ratably over the first three anniversary dates of the grant date.
- [F2]On July 28, 2016, Mr. Johnson was granted 8,333 stock options. The options vest ratably over the first three anniversary dates of the grant date.
- [F3]On May 25, 2017, Mr. Johnson was granted 10,000 stock options. The options vest ratably over the first three anniversary dates of the grant date.